Agilon Health (AGL) Disappointing Financial Results Case

• $AGL stockholder filed a claim vs. agilon health for misleading about their financial results and business prospects.

• On January 5, 2024, news of the lowering profit forecasts caused $AGL to fall 28%, losing $1.4B+ in shareholder value.

On November 2, 2023, agilon disclosed lower-than-expected Q3 results due to higher utilization and medical costs.

• Agilon decreased revenue forecast for 2023 and disclosed that agilon had raised its accounting reserve for previous medical expenses.

Following this news, $AGL dropped 13% the next day.

On January 5, 2024, agilon revealed another cut to its 2023 profit forecasts.

Additionally, they dislosed that their CFO, Timothy Bensley, would retire, to be replaced later in the year.

On this news, $AGL plummeted 28% the same day.

Based on these events, $AGL stockholder filed a claim against agilon and its leaders, accusing them of the following:

• Agilon touted its visibility into utilization trends and medical costs.

• They didn't disclose increased medical costs due to higher healthcare usage by MA patients.

Considering all the representations, investors have reasons to suspect that agilon misled about accounting reserves, business model effectiveness, and financial guidance.